case_images: PMC7115132_01
case_images: PET scan: gastrohepatic lymph node that measures 2.8 x 2.3 cm.
case_images: CRIONM2020-7075048.001.jpg
case_images: PMC7115132_01_CRIONM2020-7075048.001.jpg
case_images: fig1
case_images: An enlarged hepatic lymph node was also noted (Figure 1).
case_images: MRI of the abdomen: 2.1 cm slightly T2 hyperintense, T1 hypointense nodule in the pancreatic neck.
case_images: CRIONM2020-7075048.002.jpg
case_images: PMC7115132_01_CRIONM2020-7075048.002.jpg
case_images: fig2
case_images: An MRI of the abdomen subsequently showed a 2.1 cm mass in the pancreatic neck (Figure 2).
case_images: Upper EUS: 18 x 16 mm lesion in the pancreatic body.
case_images: CRIONM2020-7075048.003.jpg
case_images: PMC7115132_01_CRIONM2020-7075048.003.jpg
case_images: fig3
case_images: EUS showed an 18 x 16 mm hypoechoic mass in the proximal body of the pancreas (Figure 3).
case_images: CT of the abdomen: significant regression of the metastatic nodular lesion to 1.4 cm in the pancreatic neck following radiation therapy.
case_images: CRIONM2020-7075048.004.jpg
case_images: PMC7115132_01_CRIONM2020-7075048.004.jpg
case_images: fig4
case_images: Tumor Board Conference at our institution and based on his previous successful response to radiation therapy to his right orbit, he was treated with radiation (30 Gy/10 fx) to the pancreatic metastasis. There was significant regression of the pancreatic mass after radiation therapy based on the follow-up CT imaging (Figure 4).